Načítá se...
Allogeneic hematopoietic stem cell transplantation for non-malignant hematological disorders
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) from a geno-identical matched sibling (MSD) is one of the most successful therapies in patients with non-malignant hematological disorders. This study included 273 patients with severe aplastic anemia (SAA), 152 patients with B-Thalassem...
Uloženo v:
| Vydáno v: | J Adv Res |
|---|---|
| Hlavní autoři: | , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Elsevier
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4522586/ https://ncbi.nlm.nih.gov/pubmed/26257943 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jare.2014.11.001 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|